{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T18:10:16Z","timestamp":1648663816664},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.lpm.2010.02.043","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T08:58:09Z","timestamp":1271667489000},"page":"688-693","source":"Crossref","is-referenced-by-count":0,"title":["Quel traitement anti-arythmique pour la fibrillation atriale paroxystique\u00a0?"],"prefix":"10.1016","volume":"39","author":[{"given":"Fabrice","family":"Extramiana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Messali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghassan","family":"Moubarak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Leenhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2010.02.043_bib1","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2010.02.043_bib2","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","article-title":"Epidemiologic features of chronic atrial fibrillation: the Framingham study","volume":"306","author":"Kannel","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.02.043_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1540-8167.2003.00003.x","volume":"14","author":"L\u00e9vy","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.lpm.2010.02.043_bib4","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/01.CIR.99.23.3028","article-title":"Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists","volume":"99","author":"L\u00e9vy","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2010.02.043_bib5","doi-asserted-by":"crossref","unstructured":"ACC\/AHA\/ESC 2006\u00a0Guidelines for the Management of Patients With Atrial Fibrillation JACC 2006; 48:e149\u2013246.","DOI":"10.1016\/j.jacc.2006.07.018"},{"key":"10.1016\/j.lpm.2010.02.043_bib6","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.02.043_bib7","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.02.043_bib8","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.02.043_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archinte.166.7.719","article-title":"Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials","volume":"166","author":"Lafuente-Lafuente","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2010.02.043_bib10","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1161\/CIRCULATIONAHA.108.838474","article-title":"Twenty-four-hour holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy: up to 12\u00a0months experience with a novel permanently implantable heart rhythm monitor device","volume":"120","author":"Hanke","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2010.02.043_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.lpm.2010.02.043_bib12","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/01.CIR.0000118472.77237.FA","article-title":"Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"109","author":"Steinberg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2010.02.043_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.104.3.292","article-title":"Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy","volume":"104","author":"Pedersen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2010.02.043_bib14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"ATHENA Investigators. Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.02.043_bib15","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.82.4.1106","article-title":"Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials","volume":"82","author":"Coplen","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2010.02.043_bib16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators","volume":"342","author":"Roy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.02.043_bib17","unstructured":"http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/09\/briefing\/2009-4417b1-02-Sanofi_Aventis.pdf."},{"issue":"Suppl. A","key":"10.1016\/j.lpm.2010.02.043_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/eurheartj\/15.suppl_A.9","article-title":"Paroxysmal atrial fibrillation: a disorder of autonomic tone?","volume":"15","author":"Coumel","year":"1994","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2010.02.043_bib19","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4\u00a0study","volume":"118","author":"Ja\u00efs","year":"2008","journal-title":"Circulation"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821000182X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821000182X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:55:15Z","timestamp":1559051715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075549821000182X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S075549821000182X"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2010.02.043","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}